High Select has been acquired by The AccelerationGroup
High Select has established a strategic partnership with the AccelerationGroup in which the AccelerationGroup acquired a majority stake in High Select and where the owners of High Select keep a remaining minority stake. The sellers will stay on their management position within the company. Financial details have not been disclosed.
High Select offers non-patient related traineeships to companies operating in the healthcare sector. The company selects and recruits students and employs these at companies operating in the healthcare sector requesting temporary management assistance. The shareholders believe that there is significant potential for the company to grow, but it is currently restricted by a lack of capital. The shareholders were looking for an external party with both sufficient resources and industry knowledge to help further develop the company.
The AccelerationGroup, founded and managed by Gerd Koops and Lars Spannenburg, advises companies with unique business challenges in the broadest sense of the word.
Oaklins' small cap advisory team in the Netherlands helped High Select to find a strategic or financial partner who was able to further strengthen commercial activities and already had a well-established network within the healthcare sector. In addition, the partner would be able to provide additional growth capital. Our team identified The AccelerationGroup as the right fit for a strategic partnership.
Talk to the deal team
Frederik van der Schoot
Oaklins Netherlands
Related deals
Bluegem Capital Partners and AREV Partners have acquired 100% of Groupe Pinard
Bluegem Capital Partners and AREV Partners have successfully completed the acquisition of the prestigious Groupe Pinard from IK Partners.
Learn moreLumiforte partners with Kartesia to propel global growth and innovation
Lumiforte, a global leader in innovative smart coatings for greenhouse horticulture, sports line-marking and other functional coatings for agriculture and industry, is excited to announce an investment from Kartesia, a European specialist in capital solutions for small and medium-sized companies. Horticoop, a longstanding shareholder of Lumiforte and a key player in the horticultural industry through its investment cooperative, continues to remain a shareholder.
Learn morePanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production
PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.
Learn more